News & AnalysisAIDS Research

Novel Antibody Response May Explain HIV Vaccine Success

See allHide authors and affiliations

Science  16 Sep 2011:
Vol. 333, Issue 6049, pp. 1560
DOI: 10.1126/science.333.6049.1560

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A new analysis of the only AIDS vaccine trial ever to report positive results suggests that a novel antibody response led to the modest level of efficacy seen in the study. Although numerous questions remain, researchers in this failure-riddled field say the new finding may point the way to a more effective vaccine.